Please provide your email address to receive an email when new articles are posted on . O’Brien: An initial response is to consider the individual’s insurance formulary. However, when an insurance ...
A team of medical researchers affiliated with multiple institutions in the U.S. working with a colleague from Spain has found via clinical trial that adding tirzepatide (brand name Mounjaro) to basal ...
Novo Nordisk announced that the US FDA approved Awiqli injection 700 units/mL to improve glycemic control in adults with type 2 diabetes alongside diet and exercise.
PLAINSBORO, N.J., March 26, 2026 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the ...
The overall safety of insulin efsitora was similar to that of daily basal insulin therapies. Topline data were announced from 2 studies in the QWINT phase 3 clinical development program investigating ...
Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...
With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...
Novo Nordisk A/S (NYSE:NVO) is one of the 8 Dirt Cheap Stocks to Buy With $1000 Right Now. On March 27, Novo Nordisk A/S (NYSE:NVO) said that the U.S. Food and Drug Administration approved Awiqli ...
India Today on MSN
Insulin pump vs injections: Is diabetes care becoming less stressful?
Wearable insulin pumps are offering many diabetes patients an alternative to daily injections. The devices can improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results